Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bonofil-2 for critical bone defects and extra-articular comminuted fractures
MOH_2019-09-27_000632Phase 2Recruiting
- Sponsor
- Bonus Therapeutics
- Start
- Sep 2016
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of BonoFill in Bone defect and bone fracture (Fx), sponsored by Bonus Therapeutics. Started Sep 2016; status: recruiting.
02
Drugs
BonoFill
03
Conditions
Bone defectbone fracture (Fx)
Beyond the preview
Go deeper on MOH_2019-09-27_000632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-09-27_000632.